XML 125 R108.htm IDEA: XBRL DOCUMENT v3.25.0.1
FINANCIAL INSTRUMENTS - Income Statement (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Derivatives, Fair Value [Line Items]      
Net sales $ 14,086 $ 14,198 $ 12,635
Cost of sales 11,438 11,630 10,266
Selling, general and administrative expenses - R&D, net 1,350 1,316 1,290
Other comprehensive income (192) 48 (325)
Gain (loss) on cash flow hedging relationships:      
Gain (loss) recognized in other comprehensive income (loss) (2) 59 20
Gain (loss) reclassified from AOCI to income 0 0 0
Cash Flow Hedging | Foreign exchange contract | Gain (loss) reclassified from AOCI to income      
Derivatives, Fair Value [Line Items]      
Net sales 3 0 0
Cost of sales 33 0 0
Selling, general and administrative expenses - R&D, net $ (1) $ 34 $ 16